GSK CEO targets $2.5B in cost savings from mature products, procurement, supply chain

About half a year into his tenure as GSK’s CEO, Luke Miels is launch | About half a year into his tenure as GSK’s CEO, Luke Miels is launching a three-year restructuring designed to generate $2.5 billion in annual cost savings by 2029. The cost reductions will mainly be pulled from three levers, Miels explained on a call with reporters.